European Journal of Endocrinology

Article	Citations
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy	367
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19	258
Thyrotoxicosis in patients with COVID-19: the THYRCOV study	236
Management of Endocrine Disease: Osteogenesis imperfecta: an update on clinical features and therapies	113
GLOBAL ENDOCRINOLOGY: Global perspectives in endocrinology: coverage of iodized salt programs and iodine status in 2020	110
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre	95
European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARA	81
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency	80
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors	68
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study	63
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism	57
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome	56
Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality	56
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma	55
GENETICS IN ENDOCRINOLOGY: Genetic etiologies of central precocious puberty and the role of imprinted genes	53
DIAGNOSIS OF ENDOCRINE DISEASE: Diagnosing and classifying diabetes in diseases of the exocrine pancreas	53
MANAGEMENT OF ENDOCRINE DISEASE: Thyroid and female infertility: more questions than answers?!	49
DIAGNOSIS OF ENDOCRINE DISEASE: Post-pancreatitis diabetes mellitus: prime time for secondary disease	49
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation	47
The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection	46
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia	45
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement	42
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline	41
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study	40
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy	39

MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia	39
Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study	39
ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus	38
Multiple testing: when is many too much?	38
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients	37
Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?	36
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls	35
MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly?	35
Carotid body chemosensitivity: early biomarker of dysmetabolism in humans	34
Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study	34
Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism	34
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer	33
Global epidemiology of acromegaly: a systematic review and meta-analysis	33
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome	32
MANAGEMENT OF ENDOCRINE DISEASE: Male osteoporosis: diagnosis and management - should the treatment and the target be the same as for female osteoporosis?	32
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations	32
MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity	32
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome	32
MANAGEMENT OF ENDOCRINE DISEASE: Carney complex: clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene	31
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis	31
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY	31
Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus	31
Performance of EU-TIRADS in malignancy risk stratification of thyroid nodules: a meta-analysis	30
Performance of deep neural network-based artificial intelligence method in diabetic retinopathy screening: a systematic review and meta-analysis of diagnostic test accuracy	30
Circulating fatty acids and risk of gestational diabetes mellitus: prospective analyses in China	29
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19	29
The interplay of thyroid hormones and the immune system – where we stand and why we need to know about it	29
T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly	29
MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary amenorrhea and female delayed puberty	29
Effects of iodine supplementation during pregnancy on pregnant women and their offspring: a systematic review and meta-analysis of trials over the past 3 decades	28
Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing’s syndrome	28
Conventional thyroidectomy vs thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules	28
MECHANISMS IN ENDOCRINOLOGY: Local and systemic effects of glucocorticoids on metabolism: new lessons from animal models	28
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors	28
DNAJC3 deficiency induces β-cell mitochondrial apoptosis and causes syndromic young-onset diabetes	28
Missing data: the impact of what is not there	28
Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline	27
Endocrinology in the time of COVID-19: Management of pituitary tumours	27
Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments	27
MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing’s syndrome: a practical approach	27
GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus	27
When observational studies can give wrong answers: the potential of immortal time bias	26
Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study	25
MANAGEMENT OF ENDOCRINE DISEASE Subclinical hypothyroidism in children	25
MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?	24
Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard	24
Methimazole-induced remission rates in pediatric Graves’ disease: a systematic review	24
LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells	24
Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy	23
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response	23

Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study	23
MANAGEMENT OF ENDOCRINE DISEASE: Glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?	23
MANAGEMENT OF ENDOCRINE DISEASE: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease	23
ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases	23
GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas	23
Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation	22
MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people	22
Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses	22
Effect of sex and sex steroids on brown adipose tissue heat production in humans	22
Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study	22
Preferences of patients and clinicians for treatment of Graves’ disease: a discrete choice experiment	22
Effects of endogenous GIP in patients with type 2 diabetes	22
International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry	22
ENDOCRINOLOGY IN PREGNANCY: Metabolic impact of bile acids in gestation	21
Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis	21
Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia	21
MANAGEMENT OF ENDOCRINE DISEASE: Female sexual dysfunction for the endocrinologist	21
A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen	21
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study	21
Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients	20
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma	20
Efficacy and tolerance of osilodrostat in patients with severe Cushing’s syndrome due to non-pituitary cancers	20
Iodine contrast prior to or during pregnancy and neonatal thyroid function: a systematic review	20
Selective vs non-selective alpha-blockade prior to adrenalectomy for pheochromocytoma: systematic review and meta-analysis	20
New national recommendations for the treatment of pediatric differentiated thyroid carcinoma in the Netherlands	20
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension	20
Peptide hormone analysis in diagnosis and treatment of Differences of Sex Development: joint position paper of EU COST Action ‘DSDnet’ and European Reference Network on Rare Endocrine Conditions	20
The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review	20
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review	20
Health status is related to testosterone, estrone and body fat: moving to functional hypogonadism in adult men with HIV	19
Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study	19
MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions	19
THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedside	19
Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study	19
A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden	19
Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission?	19
Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial	19
Transcription factor immunohistochemistry in the diagnosis of pituitary tumours	19
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors	19
Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis	18
Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades	18
Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluation	18
Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian randomisation study	18
Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?	18
Abnormal body composition in patients with adrenal adenomas	18
MANAGEMENT OF ENDOCRINE DISEASE: Papillary thyroid microcarcinoma: toward an active surveillance strategy	18
Exposure to non-persistent pesticides and puberty timing: a systematic review of the epidemiological evidence	18
DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune–Albright syndrome and cutaneous skeletal hypophosphatemia syndrome	17
Etomidate infusion at low doses is an effective and safe treatment for severe Cushing’s syndrome outside intensive care	17
MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism	17
Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study	17
Sex-specific associations of circulating testosterone levels with all-cause and cause-specific mortality	17
Somatic mutations in adrenals from patients with primary aldosteronism not cured after adrenalectomy suggest common pathogenic mechanisms between unilateral and bilateral disease	17
Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?	17
Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study	16
Can preoperative ultrasound predict extrathyroidal extension of differentiated thyroid cancer?	16
Cabergoline should be attempted in progressing non-functioning pituitary macroadenoma	16
The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease	16
Active management of severe hyponatraemia is associated with improved mortality	16
Semen quality and testicular adrenal rest tumour development in 46,XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement	16
MANAGEMENT OF ENDOCRINE DISEASE: Postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantation	16
Effects of 8 years of growth hormone treatment on scoliosis in children with Prader–Willi syndrome	16
Using electronic health record data for clinical research: a quick guide	16
Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis	16
Risk of bone fractures after the diagnosis of adrenal adenomas: a population-based cohort study	16
MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases	15
The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes	15
MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications	15
The phenotypic spectrum associated with OTX2 mutations in humans	15
Psychological well-being and personality in relation to weight loss following behavioral modification intervention in obese women with polycystic ovary syndrome: a randomized controlled trial	15
Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism	15
MECHANISMS IN ENDOCRINOLOGY: Paracrine and endocrine control of the growth hormone axis by estrogen	15
Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience	15
Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study	15
Effect of exercise training on insulin sensitivity, hyperinsulinemia and ectopic fat in black South African women: a randomized controlled trial	14
Metabolic disease and adverse events from immune checkpoint inhibitors	14
Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study	14
Characterization of patients with adrenal insufficiency and frequent adrenal crises	14
Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register	14
Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy	14

Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening	14
Hair cortisol and cortisone measurements for the diagnosis of overt and mild Cushing’s syndrome	14
ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma	14
Steroid reference intervals in women: influence of menopause, age and metabolism	14
Patients with low IGF-I after curative surgery for Cushing’s syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy	14
Growth hormone retesting during puberty: a cohort study	14
Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study	14
Rapid control of severe ectopic Cushing’s syndrome by oral osilodrostat monotherapy	14
Genetic evaluation supports differential diagnosis in adolescent patients with delayed puberty	14
Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study	14
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension	14
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity	14
MECHANISMS IN ENDOCRINOLOGY: The gut–brain axis: regulating energy balance independent of food intake	14
Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues	13
Efficacy and tolerance of osilodrostat in patients with Cushing’s syndrome due to adrenocortical carcinomas	13
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia	13
MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: prevalence, prognostic impact, pathophysiology, and management	13
AMH as part of the diagnostic PCOS workup in large epidemiological studies	13
Familial dysalbuminaemic hyperthyroxinaemia interferes with current free thyroid hormone immunoassay methods	13
Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study	13
THERAPY OF ENDOCRINE DISEASE: Novel protection and treatment strategies for chemotherapy-associated ovarian damage	13
Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders	13
ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus	13
Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients	13
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis	13
Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?	13
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study	13
Real-life clinical impact of a five-tiered classification of pituitary tumors	13
Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior	13
Distinguishing between hidden testes and anorchia: the role of endocrine evaluation in infancy and childhood	13
Obstructive sleep apnea is not an independent determinant of testosterone in men	13
High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies	12
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study	12
Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia	12
ESE audit on management of adult growth hormone deficiency in clinical practice	12
SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years	12
Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls	12
Thyroid hormone resistance index and mortality in euthyroid subjects: [email protected] study	12
Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS	12
Classic and 11-oxygenated androgens in serum and saliva across adulthood: a cross-sectional study analyzing the impact of age, body mass index, and diurnal and menstrual cycle variation	12
Evaluation of an individualized education program in pituitary diseases: a pilot study	12
Variation in sensitivity and rate of change in body composition: steps toward individualizing transgender care	12
GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review	12
Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas	12
Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease	12
The broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series	12
Prevalence and progression of aortic dilatation in adult patients with Turner syndrome: a cohort study	12
Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report	12
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial	12
Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease	12
The influence of age on disease outcome in 2015 ATA high-risk differentiated thyroid cancer patients	12
MANAGEMENT OF ENDOCRINE DISEASE Disease burden and treatment challenges in patients with both Addison’s disease and type 1 diabetes mellitus	11
Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study	11
Persistent cortisol response to desmopressin predicts recurrence of Cushing’s disease in patients with post-operative corticotropic insufficiency	11
Introduction to diagnostic test accuracy studies	11
Treatment of acromegaly has substantial effects on body composition: a long-term follow-up study	11
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome	11
Dopamine agonists and antipsychotics	11
Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer	11
Clinical course and imaging characteristics of benign adrenal cysts: a single-center study of 92 patients	11
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma	11
Updated clinical management guidance during the COVID-19 pandemic: thyroid nodules and cancer	11
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma	11
Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study	11
Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study	11
Outcomes of repeat fineneedle aspiration biopsy for AUS/FLUS thyroid nodules	11
Cardiovascular prognostic value of echocardiography and N terminal pro B-type natriuretic peptide in type 1 diabetes: the Thousand & 1 Study	11
Pubertal development and premature ovarian insufficiency in patients with APECED	11
Long-term morbidity and mortality in patients diagnosed with an insulinoma	11
Insulin resistance and risk of vascular events, interventions and mortality in type 1 diabetes	11
Clinical utility of sonographic features in indeterminate pediatric thyroid nodules	11
Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification	11
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer	11
Circadian rhythms of 11-oxygenated C19 steroids and ∆5-steroid sulfates in healthy men	11
Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank	11
A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies	11
Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients	11